BRCA1 and triple-negative breast carcinoma: Since induction of BRCA1 expression has been shown to inhibit growth in breast tumors and cell lines [21], this result is consistent with a role of miR-498 in the inhibition of BRCA1. Hence, our data support that miR-498 promotes cell proliferation in triple negative breast cancer through direct regulation of BRCA1 expression.